OM Pharma
E-mail: mailbox@ompharma.com
Web: https://www.ompharma.com/
OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections, also active in the treatment of vascular diseases. OM Pharma’s marketed portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies (for example diabetic retinopathy), hemorrhoids and menometrorrhagia (heavy menstrual bleeding). Broncho-Vaxom® and Uro-Vaxom® products are manufactured in Geneva and distributed in more than 100 countries across the world.
For detailed contact information visit location pages below.
OM Pharma's locations around the world
Europe
Clinical Trials sponsored by OM Pharma
-
OM Pharma SATerminatedAtopic DermatitisGermany, France, Poland, Netherlands
-
OM Pharma SAActive, not recruitingRespiratory Tract Infections | Wheezing Lower Respiratory IllnessUnited Kingdom, Hungary, Poland, Switzerland, Germany, Italy
-
OM Pharma SACompleted
-
OM Pharma SAParexelActive, not recruitingRecurrent Wheezing | Wheezing Lower Respiratory IllnessUnited States, Poland, Australia, Hungary
-
Campus Bio-Medico UniversityOM Pharma SARecruitingRespiratory Tract Infections (RTI)Italy
-
AJU Pharm Co., Ltd.OM Pharma SARecruitingChronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain SyndromeKorea, Republic of
-
Hervé SPECHBACHOM Pharma SACompletedCOVID-19 Virus DiseaseSwitzerland
-
Fondazione Policlinico Universitario Campus Bio-MedicoOM Pharma SAActive, not recruitingRespiratory Tract Infections (RTI)Italy
-
University of North Carolina, Chapel HillUniversity of Amsterdam; Crohn's and Colitis Foundation; OM Pharma SATerminatedCrohn Disease | Pediatric Crohns DiseaseUnited States, Netherlands, Canada, Israel